Skip to contentSANOFI-AVENTIS — REGENERON PHARMACEUTICALS INC insider: 588 transactions · InsiderLensSANOFI-AVENTIS
- 10% owner at MeiraGTx Holdings plc · on record since Aug 13, 2024
- 10% owner at CHATTEM INC · on record since Feb 11, 2010
- 10% owner at REGENERON PHARMACEUTICALS INC · on record since Dec 21, 2007
- Exiting 10% owner at IDM PHARMA, INC. · on record since Feb 11, 2008
- 10% owner at GENZYME CORP · on record since Apr 8, 2011
- 10% owner at KALOBIOS PHARMACEUTICALS INC · on record since Aug 10, 2012
- 10% owner at Regulus Therapeutics Inc. · on record since Oct 9, 2012
- Former 10% owner at KALOBIOS PHARMACEUTICALS INC · on record since Feb 7, 2013
- 10% owner at GLYCOMIMETICS INC · on record since Nov 7, 2013
- 10% owner at ALNYLAM PHARMACEUTICALS, INC. · on record since Mar 27, 2014
- 10% owner at SCYNEXIS INC · on record since May 9, 2014
- 10% owner at IDM PHARMA, INC. · on record since Aug 26, 2005
- 10% owner at Icosavax, Inc. · on record since Jul 28, 2021
- 10% owner at MyoKardia Inc · on record since Oct 28, 2015
- Former 10% owner at Voyager Therapeutics, Inc. · on record since Nov 18, 2015
- 10% owner at Voyager Therapeutics, Inc. · on record since Nov 12, 2015
- 10% owner at Fulcrum Therapeutics, Inc. · on record since Jul 23, 2019
- 10% owner at Inozyme Pharma, Inc. · on record since Jul 29, 2020
- 10% owner at TRANSGENOMIC INC · on record since Sep 14, 2021
- See Remarks below at TRANSGENOMIC INC · on record since Aug 12, 2021
Insider trading activity of SANOFI-AVENTIS
- Transactions on record
- 588
- since Feb 11, 2008
- Open-market buys
- 565
- $10.1B
- Open-market sells
- 9
- $12.1B
- Companies traded
- 12
- last filing Sep 14, 2021
Figures computed from official regulatory filings — methodology.
Companies where SANOFI-AVENTIS has traded
- TRANSGENOMIC INC2 tx · $2.7B · Sep 14, 2021
- Icosavax, Inc.4 tx · $1M · Aug 2, 2021
- Inozyme Pharma, Inc.3 tx · $1.3M · Jul 29, 2020
- REGENERON PHARMACEUTICALS INC550 tx · $14.4B · Jun 11, 2020
- Fulcrum Therapeutics, Inc.3 tx · $1.5M · Jul 23, 2019
- MyoKardia Inc8 tx · $192.5M · Feb 15, 2019
- ALNYLAM PHARMACEUTICALS, INC.7 tx · $2B · Jun 1, 2017
- Voyager Therapeutics, Inc.3 tx · $1.8M · Nov 18, 2015
- Regulus Therapeutics Inc.1 tx · $10M · Feb 5, 2014
Track record of SANOFI-AVENTIS
Statistical track record
Free- Open-market buys
- 565
- Last buy
- Sep 14, 2021
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of SANOFI-AVENTIS
Co-insiders of SANOFI-AVENTIS
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
2 tx · $700K · Feb 7, 2013
Shah Rajeev M.Fulcrum Therapeutics, Inc. +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Sep 14, 2021 | Buy | 20,515,985 | 38.00 USD | $779.6M | SEC |
| Sep 14, 2021 | Buy | 51,467,612 | 38.00 USD | $2B | SEC |
| Aug 2, 2021 | OtherD | -12,480,498 | — | — | SEC |
| Aug 2, 2021 | Buy | 66,667 | 15.00 USD | $1M | SEC |
| Aug 2, 2021 | OtherD | -354,393 | — | — | SEC |
| Aug 2, 2021 | Other | 3,088,502 | 0.00 USD | $0 | SEC |
| Jul 29, 2020 | OtherD | -3,279,720 | 0.00 USD | $0 | SEC |
| Jul 29, 2020 | Buy | 81,250 | 16.00 USD | $1.3M | SEC |
| Jul 29, 2020 | Other | 438,875 | 0.00 USD | $0 | SEC |
| Jun 11, 2020 | Sell | -120,234 | 597.48 USD | $71.8M | SEC |
| May 29, 2020 | Sell | -20,421,899 | 509.85 USD | $10.4B | SEC |
| May 29, 2020 | Sell | -2,399,552 | 509.85 USD | $1.2B | SEC |
| Mar 11, 2020 | Sell | -128,914 | 489.65 USD | $63.1M | SEC |
| Sep 12, 2019 | Sell | -172,904 | 281.15 USD | $48.6M | SEC |
| Jul 23, 2019 | Buy | 93,750 | 16.00 USD | $1.5M | SEC |
| Jul 23, 2019 | Other | 464,285 | 0.00 USD | $0 | SEC |
| Jul 23, 2019 | OtherD | -3,250,000 | 0.00 USD | $0 | SEC |
| Mar 12, 2019 | Sell | -131,115 | 412.17 USD | $54M | SEC |
| Feb 15, 2019 | Sell | -4,168,899 | 37.66 USD | $157M | SEC |
| Sep 10, 2018 | Sell | -104,552 | 406.68 USD | $42.5M | SEC |
| Jun 11, 2018 | Sell | -121,601 | 309.31 USD | $37.6M | SEC |
| May 29, 2018 | Buy | 150,000 | 49.00 USD | $7.4M | SEC |
| Aug 29, 2017 | Buy | 5,723 | 485.28 USD | $2.8M | SEC |
| Aug 29, 2017 | Buy | 28,586 | 479.93 USD | $13.7M | SEC |
| Aug 29, 2017 | Buy | 21,360 | 480.75 USD | $10.3M | SEC |